Innovative approaches are already revolutionising the treatment of hematological diseases, yet research is working to make them more accessible and more powerful
In the tyrosine kinase inhibitors era, patients can safely plan pregnancy which in most cases results in labour when the right treatment and good compliance are applied
The public-private partnership has already reached several milestones, paving the way to answer the key questions in the field of haematological malignancies
The increasing use of immuno- and targeted therapies demands oncologists to learn how to recognize and treat adverse events and complications they are not familiar with
Univadis - en service från MSD
